PharmaCyte Biotech Inc (PMCB) — Net Asset Momentum
PharmaCyte Biotech Inc (PMCB) recorded a net asset momentum of 31.3% as of April 2025, with net assets of $51.89 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check PharmaCyte Biotech Inc (PMCB) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
PharmaCyte Biotech Inc Net Asset Momentum (2004–2025)
This chart tracks PharmaCyte Biotech Inc's year-over-year net asset growth across 22 annual reporting periods from 2004 to 2025. The most recent momentum reading is +31.3%, with net assets of $51.89 Million USD as of April 2025. Read PharmaCyte Biotech Inc debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for PharmaCyte Biotech Inc (2004–2025)
The table below shows the complete annual net asset history for PharmaCyte Biotech Inc from 2004 to 2025, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PMCB company net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $51.89 Million | $55.17 Million | $3.28 Million | ▲ +31.3% |
| 2024 | $39.51 Million | $59.90 Million | $20.39 Million | ▼ -45.6% |
| 2023 | $72.69 Million | $73.28 Million | $586.58K | ▼ -19.2% |
| 2022 | $89.92 Million | $90.62 Million | $704.37K | ▲ +1246.2% |
| 2021 | $6.68 Million | $7.40 Million | $724.78K | ▲ +31.3% |
| 2020 | $5.09 Million | $6.17 Million | $1.08 Million | ▲ +1.0% |
| 2019 | $5.04 Million | $5.78 Million | $742.85K | ▼ -12.6% |
| 2018 | $5.77 Million | $6.41 Million | $644.17K | ▼ -28.7% |
| 2017 | $8.09 Million | $8.67 Million | $580.25K | ▲ +24.0% |
| 2016 | $6.52 Million | $7.16 Million | $637.64K | ▲ +9.9% |
| 2015 | $5.94 Million | $7.95 Million | $2.01 Million | ▼ -33.6% |
| 2014 | $8.94 Million | $9.32 Million | $373.67K | ▲ +1070.5% |
| 2013 | $-921.46K | $2.88 Million | $3.80 Million | ▲ +59.6% |
| 2012 | $-2.28 Million | $2.09 Million | $4.37 Million | ▲ +16.5% |
| 2011 | $-2.73 Million | $1.24 Million | $3.97 Million | ▼ -39.9% |
| 2010 | $-1.95 Million | $1.20 Million | $3.15 Million | ▼ -148.9% |
| 2009 | $3.99 Million | $6.84 Million | $2.85 Million | ▼ -46.3% |
| 2008 | $7.44 Million | $7.62 Million | $180.56K | ▲ +73.5% |
| 2007 | $4.29 Million | $4.41 Million | $118.81K | ▼ -2.8% |
| 2006 | $4.41 Million | $5.14 Million | $723.89K | ▲ +440.7% |
| 2005 | $-1.30 Million | $336.36K | $1.63 Million | ▼ -744.1% |
| 2004 | $-153.43K | $175.71K | $329.13K | — |